General
"Oncology" (teaching slides for geriatrics residents). American Geriatrics Society, http://teachingslides.americangeriatrics.org, April 2007. [BAC and FR, writers]
Educational website content about recent developments in cancer (biologic and targeted therapies, gene therapy, therapeutic vaccines, and individualized treatment), prepared January to June 2007. [BAC, writer]
Quantitative literature analyses about: a hematopoietic growth factor (prepared April 2005), a novel leukemia drug (March 2005), a novel taxane (February 2005), monoclonal antibodies for breast cancer (February 2005), a novel anthracenedione (February 2005), and various antimicrobials (January 2005). [BAC, researcher]
Walsh JME. Controversies in cancer prevention and screening. Adv
Stud Med. 2003;
3(6):316-325. [BAC and FR, collaborating writers]
Bladder cancer
Caley BA. Bladder cancer: breaking the research barrier. CURE: Cancer Updates, Research and Education. 2006;5(5):34-39,44-45.
Breast cancer
Needs assessment for CME program on managing pretreated metastatic breast cancer, prepared May 2010. [BAC and FR, writers]
Benchmarking report on current third-line treatment of breast cancer, prepared July 2009. [BAC, writer]
Slide sets on breast cancer-related abstracts and posters presented at ASCO 2009, prepared June 2009. [BAC, writer]
Detailed summaries of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer, prepared June 2008 to September 2008. [FR, writer]
Three posters for ASCO annual meeting about anti-angiogenic treatment of breast and ovarian cancer, prepared April 2008. [FR, collaborating writer]
Same-day Internet reports from the San Antonio Breast Cancer Symposium, prepared for CURE magazine, December 2008. [BAC, writer]
Preventing death from breast cancer and prostate cancer. Prepared for Taking Care, November 2005. [BAC, writer]
Meeting report, national breast cancer advisory board, prepared June 2005. [FR, writer]
Meeting report, national breast cancer advisory board, prepared June 2004. [BAC, writer]
Caley BA and Reidenbach F. Expanding options for advanced breast cancer. CURE: Cancer Updates, Research and Education. 2003;2(3):47-53.
Reidenbach F. Gabapentin may relieve tamoxifen-related hot flushes. Lancet Oncol. 2002;3:393.
Reidenbach F. Novel predictor of breast cancer survival called the most powerful to date. Reuters news, 11-14-2002.
Reidenbach F. Anthracycline/taxane neoadjuvant chemotherapy advised for breast cancer. Reuters news, 4-9-2002.
Reidenbach F. Clues to why breast cancer more often fatal in African Americans. Reuters news, 2-7-2002.
Reidenbach F. Postmastectomy radiation may be warranted after response to chemotherapy. Reuters news, 1-30-2002.
Reidenbach F. Incident breast lesions found on MRI unlikely to be malignant. Reuters news, 12-2-1998.
Reidenbach F. Adjuvant chemotherapy prolongs survival in high-risk node-negative breast cancer. Reuters news, 10-30-1998.
Cancer surgery
Caley BA. Surgeons and robots: minimally invasive technologies transform the landscape of cancer surgery. CURE: Cancer Updates, Research and Education. 2007;6(4). Also wrote sidebar: Less can be more in diagnostic imaging.
Qualitative literature review on video-assisted thoroscopic lobectomy, prepared May 2007. [FR, researcher]
Carcinoid tumor
Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor, prepared November 2005. [FR, writer]
Cervical cancer
CME newsletter about the burden of cervical cancer, prepared September 2006. [FR, writer]
Reidenbach F. Public funding of Pap tests linked to lower rate of invasive cervical cancer. Reuters news, 7-5-2002.
Reidenbach F. Enhanced Pap testing cost effective for infrequent screening. Reuters news, 1-27-1999.
Colorectal cancer
Script for sales training video on KRAS as a biomarker for response to treatment of colorectal cancer, prepared October 2009. [BAC, writer]
Detailed summaries of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer, prepared June 2008 to September 2008. [FR, writer]
Educational website content for patients with colorectal cancer, prepared January to June 2007. [BAC, writer]
Poster for ASCO annual meeting about outcome measures for clinical trials of agents for metastatic colorectal cancer, prepared April 2006. [FR, collaborating writer]
Review about the safety of using an antiangiogenic agent to treat metastatic colorectal cancer, prepared March 2006. [FR, collaborating writer]
Reidenbach F. Gene may help suppress colorectal cancer. Reuters news, 2-28-2002.
Reidenbach F. Calcium reduces risk of colorectal polyps. Reuters news, 1-13-1999.
Reidenbach F. Clinical findings predict DNA-repair gene mutations in colorectal cancer. Reuters news, 8-20-1998.
Head and neck cancer
Review of the use of immunotherapy in head and neck cancer, prepared November 2008. [BAC and FR, collaborating writers]
Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor, prepared November 2005. [FR, writer]
Lung cancer
Sales rep training material about targeted therapy for non-small-cell lung cancer, prepared June 2008, February 2009, and September 2009. [FR, writer]
Qualitative literature review on video-assisted thoroscopic lobectomy, prepared May 2007. [FR, researcher]
Educational website content for patients with non-small-cell or small-cell lung cancer, prepared January to June 2007. [BAC, writer]
The health consequences of smoking. In: Attorneys’ Textbook of Medicine. New York, NY: Matthew Bender, 2006. [BAC, collaborating writer]
Review about trends in chemotherapy for lung cancer, prepared July 2005. [FR, collaborating writer]
Quantitative literature analysis regarding chemotherapy for non-small-cell lung cancer, prepared April 2004. [BAC, researcher]
Reidenbach F. Early radiation advised for limited-stage small-cell lung cancer. Reuters news, 8-7-2002.
Reidenbach F. Spiral CT promising for lung cancer screening. Reuters news, 8-2-2002.
Reidenbach F. p53 appears to inhibit angiogenesis in non-small-cell lung cancer. Reuters news, 3-13-2002.
Ovarian cancer
Detailed summaries of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer, prepared June 2008 to September 2008. [FR, writer]
Three posters for ASCO annual meeting about anti-angiogenic treatment of breast and ovarian cancer, prepared April 2008. [FR, collaborating writer]
Reidenbach F. Blood test may screen for ovarian cancer. Reuters news, 8-25-1998.
Pathology and staging
Pathology and staging. CURE: Cancer Updates, Research and Education. 2007;6(1):8,11-13. [BAC, writer]
Pancreatic cancer
Reidenbach F. Sales rep training material about targeted therapy for pancreatic cancer, prepared June 2008, February 2009, and September 2009.
Reidenbach F. Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor, prepared November 2005.
Reidenbach F. Statins might fight spread of pancreatic cancer. Reuters news, 3-29-2002.
Prostate cancer
Review about protection against bone loss in patients with nonmetastatic prostate cancer who receive androgen deprivation therapy, prepared October 2009. [FR, collaborating writer]
Review about the safety of testosterone replacement therapy with regard to prostate cancer, prepared April 2006. [BAC and FR, collaborating writers]
Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor, prepared November 2005. [FR, writer]
Preventing death from breast cancer and prostate cancer. Prepared for Taking Care, November 2005. [BAC, writer]
Reidenbach F. Telomerase immunoreactivity of prostate tumors may have diagnostic value. Reuters news, 12-27-2002.
Reidenbach F. Level of p27 predicts outcome in localized prostate cancer. Reuters news, 6-17-1998.
Renal cell carcinoma
Case-based CME program about management of renal cell carcinoma, prepared January 2011.
Detailed summaries of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer, prepared June 2008 to September 2008. [FR, writer]
Capecitabine promising for advanced renal cell carcinoma, 1-23-2002. [FR, writer]
Sarcoma
Caley, BA. The new sarcoma story: strategies for diagnosing and treating sarcomas shift to a more patient-specific approach. CURE: Cancer Updates, Research and Education. 2007;6(5):42-49.
Supportive care generally
Meeting report, national advisory board on supportive care in cancer, prepared September 2005. [FR, writer]
Posters for ASH, ASCO, and MASCC/ISOO annual meetings, 2005. Multiple topics regarding supportive care for cancer patients. [FR, writer]
Posters for ASCO and MASCC/ISOO annual meetings, 2004. Multiple topics regarding supportive care for cancer patients. [FR, collaborating writer]
Supportive care -- anemia
Strategic analyses for the manufacturer of an erythropoiesis-stimulating agent, prepared May to December 2009. [BAC, researcher]
Quantitative literature analysis about erythropoiesis-stimulating agents, prepared May 2008. [BAC, researcher]
Quantitative literature analysis about erythropoiesis-stimulating agents, prepared May 2006. [BAC, researcher]
Supportive care -- anticoagulation
Needs assessment for CME program on preventing venous thromboembolism in cancer patients, prepared June 2010. [BAC and FR, writers]
Supportive care -- bone metastases
Monograph about the use of a RANKL inhibitor for prevention of cancer treatment-induced bone loss, prepared June 2010. [FR, writer]
Review about protection against bone loss in patients with nonmetastatic prostate cancer who receive androgen deprivation therapy, prepared October 2009. [FR, collaborating writer]
Slide libraries summarizing all major clinical trials on the use of bisphosphonates to treat skeletal-related events in breast, lung, prostate, and renal cancer and multiple myeloma, prepared December 2007 to July 2008. [BAC and FR, writers]
Supportive care -- mucositis
Report on a phase III clinical trial of the use of an anti-mucositis agent in head and neck cancer patients, prepared September 2008. [FR, collaborating writer]
3-article journal supplement about identification and treatment of oral mucositis, prepared January 2007. [FR, collaborating writer]
Investigator newsletters reporting on clinical trials of a therapy for oral mucositis, prepared September 2006 and March 2007. [FR, writer]
Supportive care -- neutropenia
Pair of review articles about under-reporting of myelotoxicity associated with emerging regimens for solid tumors (prepared April 2010) and hematologic malignancies (prepared August 2010). [FR, collaborating writer]
Pair of news pieces for nurses about preventing and managing febrile neutropenia in cancer patients (prepared March and June 2010). [FR, writer]
Review of neutropenia management in older cancer patients, prepared August 2008. [FR, collaborating writer]
Survivorship issues
Caley BA. Taking control: cancer patients deal with fear. CURE: Cancer Updates, Research and Education. 2006;5(3):64-68.
Caley BA. Going against the odds [living with metastatic cancer]. CURE: Cancer Updates, Research and Education. 2005;4(2):56-58,60. Also wrote two of the three sidebars to this article: Disrupting metastasis; The future of metastasis treatment.
Herman R. Cultural diversity and cancer patient education. Poster presented at the 2004 annual meeting of the Oncology Nursing Society. [FR, collaborating writer]
Reidenbach F. Conceiving solutions: Fertility and cancer treatment. CURE: Cancer Updates, Research and Education. 2002;1(4):22-26.
Reidenbach F. Chemotherapy safe in pregnancy. Lancet Oncol. 2002;3:128.
Reidenbach F. Mental difficulties can persist long after chemotherapy. Reuters news, 2-11-2002.
Targeted therapy generally
Slide set for a physician audience explaining the differences between small-molecule drugs, biologics, and biosimilars, prepared October 2010.
Primary clinical trial report on nursing management of toxicities related to EGFR inhibitor therapy in Europe, prepared February 2010. Also a poster for ASCO, prepared March 2010. [FR, collaborating writer]
Quantitative literature review about angiogenesis inhibitors, prepared May 2006. [BAC, researcher]
Review about the safety of using anti-angiogenic therapy in elderly patients or patients with poor performance status, prepared January 2006. [FR, collaborating writer]
Meeting report, national advisory board on angiogenesis inhibitors, prepared December 2005. [FR, writer]
Educational newsletter for sales representatives about targeted therapy, prepared Spring 2004. [FR, writer]
Reidenbach F. Angiogenesis inhibitor plus paclitaxel well tolerated in phase I trial. Reuters news, 12-5-2002.
Reidenbach F. Resistance to antiangiogenic agents may reflect variance in tumor biology. Reuters news, 10-03-2002.
Reidenbach F. First cholinergic pathway for angiogenesis identified. Reuters news, 9-10-2002.
Thyroid cancer
Are thyroid nodules cancerous? Prepared for Taking Care, October 2005. [BAC, writer]